Migraine Management
portes grátis
Migraine Management
Matharu, Manjit; Swanson, Jerry W.
Elsevier Science Publishing Co Inc
03/2024
632
Dura
Inglês
9780128233573
15 a 20 dias
Descrição não disponível.
Section I. Migraine Management
1. Non-specific analgesics, combination analgesics, and antiemetics
2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans
3. 5-HT1F agonists
4. CGRP receptor antagonists (Gepants)
5. Preventive treatment of migraine: Non-specific oral agents
6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
8. Nutraceuticals in migraine
9. Interventional treatments
10. Biobehavioral treatments of migraine
11. Physical treatment of migraine
12. Neuromodulation in migraine
Section II. Guidelines
13. Evidence-based symptomatic treatment of migraine
14. Evidence-based preventive treatment of migraine
Section III. Special Cases/Situations
15. Treatment in the emergency department
16. Special considerations in migraine during pregnancy and lactation
17. Special considerations in management of migraine in the elderly
18. Management of medication overuse headache
Section IV. Outcome Measures
19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment
Section V. Diagnosis and Treatment of Other Migraine Subtypes
20. Menstrually associated migraine
21. Hemiplegic migraine
22. Migraine with brainstem aura
23. Retinal migraine
24. Vestibular migraine and persistent postural perceptual dizziness
25. Status migrainosus
26. Persistent aura, visual snow, and other visual symptoms
27. Migrainous infarction
28. Migraine in children and adolescents: Assessment and diagnosis
29. Management of migraine in children and adolescents
Section VI. Comorbidities of Migraine
30. Psychiatric comorbidities of migraine
31. Relationship of migraine and other forms of chronic pain
32. Comorbidities of migraine: Sleep disorders
33. The evolving concept of multimorbidity and migraine
Section VII. Future Directions
34. Healthcare disparities faced by patients with migraine and potential mitigation strategies
35. Emerging and future directions of migraine research and treatment
1. Non-specific analgesics, combination analgesics, and antiemetics
2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans
3. 5-HT1F agonists
4. CGRP receptor antagonists (Gepants)
5. Preventive treatment of migraine: Non-specific oral agents
6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
8. Nutraceuticals in migraine
9. Interventional treatments
10. Biobehavioral treatments of migraine
11. Physical treatment of migraine
12. Neuromodulation in migraine
Section II. Guidelines
13. Evidence-based symptomatic treatment of migraine
14. Evidence-based preventive treatment of migraine
Section III. Special Cases/Situations
15. Treatment in the emergency department
16. Special considerations in migraine during pregnancy and lactation
17. Special considerations in management of migraine in the elderly
18. Management of medication overuse headache
Section IV. Outcome Measures
19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment
Section V. Diagnosis and Treatment of Other Migraine Subtypes
20. Menstrually associated migraine
21. Hemiplegic migraine
22. Migraine with brainstem aura
23. Retinal migraine
24. Vestibular migraine and persistent postural perceptual dizziness
25. Status migrainosus
26. Persistent aura, visual snow, and other visual symptoms
27. Migrainous infarction
28. Migraine in children and adolescents: Assessment and diagnosis
29. Management of migraine in children and adolescents
Section VI. Comorbidities of Migraine
30. Psychiatric comorbidities of migraine
31. Relationship of migraine and other forms of chronic pain
32. Comorbidities of migraine: Sleep disorders
33. The evolving concept of multimorbidity and migraine
Section VII. Future Directions
34. Healthcare disparities faced by patients with migraine and potential mitigation strategies
35. Emerging and future directions of migraine research and treatment
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Migraine; headache; pain
Section I. Migraine Management
1. Non-specific analgesics, combination analgesics, and antiemetics
2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans
3. 5-HT1F agonists
4. CGRP receptor antagonists (Gepants)
5. Preventive treatment of migraine: Non-specific oral agents
6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
8. Nutraceuticals in migraine
9. Interventional treatments
10. Biobehavioral treatments of migraine
11. Physical treatment of migraine
12. Neuromodulation in migraine
Section II. Guidelines
13. Evidence-based symptomatic treatment of migraine
14. Evidence-based preventive treatment of migraine
Section III. Special Cases/Situations
15. Treatment in the emergency department
16. Special considerations in migraine during pregnancy and lactation
17. Special considerations in management of migraine in the elderly
18. Management of medication overuse headache
Section IV. Outcome Measures
19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment
Section V. Diagnosis and Treatment of Other Migraine Subtypes
20. Menstrually associated migraine
21. Hemiplegic migraine
22. Migraine with brainstem aura
23. Retinal migraine
24. Vestibular migraine and persistent postural perceptual dizziness
25. Status migrainosus
26. Persistent aura, visual snow, and other visual symptoms
27. Migrainous infarction
28. Migraine in children and adolescents: Assessment and diagnosis
29. Management of migraine in children and adolescents
Section VI. Comorbidities of Migraine
30. Psychiatric comorbidities of migraine
31. Relationship of migraine and other forms of chronic pain
32. Comorbidities of migraine: Sleep disorders
33. The evolving concept of multimorbidity and migraine
Section VII. Future Directions
34. Healthcare disparities faced by patients with migraine and potential mitigation strategies
35. Emerging and future directions of migraine research and treatment
1. Non-specific analgesics, combination analgesics, and antiemetics
2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans
3. 5-HT1F agonists
4. CGRP receptor antagonists (Gepants)
5. Preventive treatment of migraine: Non-specific oral agents
6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
8. Nutraceuticals in migraine
9. Interventional treatments
10. Biobehavioral treatments of migraine
11. Physical treatment of migraine
12. Neuromodulation in migraine
Section II. Guidelines
13. Evidence-based symptomatic treatment of migraine
14. Evidence-based preventive treatment of migraine
Section III. Special Cases/Situations
15. Treatment in the emergency department
16. Special considerations in migraine during pregnancy and lactation
17. Special considerations in management of migraine in the elderly
18. Management of medication overuse headache
Section IV. Outcome Measures
19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment
Section V. Diagnosis and Treatment of Other Migraine Subtypes
20. Menstrually associated migraine
21. Hemiplegic migraine
22. Migraine with brainstem aura
23. Retinal migraine
24. Vestibular migraine and persistent postural perceptual dizziness
25. Status migrainosus
26. Persistent aura, visual snow, and other visual symptoms
27. Migrainous infarction
28. Migraine in children and adolescents: Assessment and diagnosis
29. Management of migraine in children and adolescents
Section VI. Comorbidities of Migraine
30. Psychiatric comorbidities of migraine
31. Relationship of migraine and other forms of chronic pain
32. Comorbidities of migraine: Sleep disorders
33. The evolving concept of multimorbidity and migraine
Section VII. Future Directions
34. Healthcare disparities faced by patients with migraine and potential mitigation strategies
35. Emerging and future directions of migraine research and treatment
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
